Clinical trialNCT05868629RecruitingObservational

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

SponsorNovartis PharmaceuticalsEnrollment40Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Novartis Pharmaceuticals
Novartis Pharmaceuticals
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Lundquist Inst Biomed at Harbor
Torrance, California, United States
Andrew Gianoukakis
Recruiting
Rocky Mountain Cancer Centers
Denver, Colorado, United States
Muath Dawod
Recruiting
Johns Hopkins University
Washington D.C., District of Columbia, United States
Michael Pishvaian
Recruiting
Duke Clinical Research Institute
Durham, North Carolina, United States
Aman Opneja
Recruiting
Oncology Hematology Care Inc
Cincinnati, Ohio, United States
Jayadev Mettu
Recruiting
Sarah Cannon Research Institute
Nashville, Tennessee, United States
Meredith Ann McKean
Recruiting
El Paso Texas Oncology
El Paso, Texas, United States
Ines Sanchez-Rivera
Recruiting
Texas Oncology San Antonio
San Antonio, Texas, United States
Angel Mier-Hicks
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 6 Feb 2024
Primary completion: 3 Mar 2028
Completion: 3 Mar 2028
Last update posted: 1 Apr 2026
Registered enrollment: 40
Registry id: NCT05868629

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.